NeoGenomics, Inc.

NEO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$79-$88-$144-$8
Dep. & Amort.$73$73$69$53
Deferred Tax$0$0-$16$0
Stock-Based Comp.$33$25$25$22
Change in WC-$33-$25-$32-$5
Other Non-Cash$12$14$32-$90
Operating Cash Flow$7-$2-$66-$27
Investing Activities
PP&E Inv.-$41-$29-$31-$64
Net Acquisitions$0$0$0-$419
Inv. Purchases$0-$7-$98-$197
Inv. Sales/Matur.$54$112$117$63
Other Inv. Act.$0$0$12-$15
Investing Cash Flow$13$77$1-$632
Financing Activities
Debt Repay.$0-$0-$1$334
Stock Issued$5$5$13$423
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$32
Financing Cash Flow$5$5$12$725
Forex Effect$0$0$0$0
Net Chg. in Cash$25$79-$54$66
Supplemental Information
Beg. Cash$342$263$317$251
End Cash$367$342$263$317
Free Cash Flow-$34-$31-$97-$91
NeoGenomics, Inc. (NEO) Financial Statements & Key Stats | AlphaPilot